• LAST PRICE
    172.8500
  • TODAY'S CHANGE (%)
    Trending Up1.8200 (1.0641%)
  • Bid / Lots
    152.3800/ 1
  • Ask / Lots
    180.0000/ 1
  • Open / Previous Close
    171.0000 / 171.0300
  • Day Range
    Low 169.7600
    High 176.0000
  • 52 Week Range
    Low 126.9681
    High 245.7400
  • Volume
    275,361
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 171.03
TimeVolumeBGNE
09:32 ET2251171
09:34 ET630170.28
09:36 ET200170.38
09:38 ET400170.795
09:39 ET500170.73
09:41 ET1162169.76
09:43 ET100170.515
09:45 ET1283170.66
09:48 ET1300170.595
09:50 ET200171.075
09:52 ET300170.49
09:54 ET200170.46
09:56 ET300170.27
09:57 ET400170.27
09:59 ET100170.46
10:01 ET600170.16
10:03 ET150170.1083
10:06 ET500170.4025
10:08 ET500170.81
10:12 ET200171.1
10:15 ET300170.73
10:17 ET100170.86
10:19 ET204170.9736
10:21 ET300170.6
10:24 ET600170.66
10:26 ET200170.91
10:28 ET300170.975
10:30 ET400170.8325
10:32 ET100170.895
10:33 ET900171.125
10:35 ET1882171.055
10:37 ET995171.388
10:42 ET100171.135
10:44 ET300171.245
10:46 ET100171.45
10:50 ET1600171.57
10:53 ET200171.215
10:55 ET100171.25
10:57 ET100171.295
11:00 ET100171.1775
11:02 ET100171.185
11:04 ET200171.185
11:06 ET1900171.4
11:11 ET1188172.29
11:13 ET200172.24
11:18 ET800171.93
11:20 ET200171.99
11:22 ET400172.18
11:24 ET200171.805
11:26 ET770171.8
11:27 ET200172.165
11:31 ET529171.97
11:33 ET4497172.1063
11:36 ET500171.7055
11:38 ET5100172.785
11:40 ET1100172.96
11:42 ET3200172.995
11:44 ET5969172.995
11:45 ET600173.02
11:49 ET888173.0175
11:51 ET400173.24
11:54 ET300173
11:56 ET1300173.24
11:58 ET400173.24
12:00 ET300173.17
12:02 ET5800174.36
12:03 ET9922174.87
12:05 ET5882174.56
12:07 ET704174.67
12:09 ET100174.5
12:12 ET698174.81
12:14 ET591175.035
12:16 ET600174.8
12:18 ET1025174.365
12:20 ET200174.32
12:21 ET300174.57
12:23 ET300174.7625
12:27 ET100175.38
12:30 ET728175.44
12:32 ET100175.32
12:34 ET200175.27
12:36 ET100175.44
12:38 ET1185175.79
12:39 ET200175.98
12:41 ET200175.705
12:43 ET300175.68
12:45 ET399175.25
12:50 ET2792174.755
12:52 ET500175.26
12:54 ET100175.39
12:57 ET636175.39
12:59 ET799175.8002
01:01 ET800175.96
01:03 ET200175.93
01:06 ET100175.93
01:08 ET100175.695
01:10 ET1713175.63
01:12 ET200174.915
01:14 ET300174.73
01:15 ET400174.675
01:17 ET500174.13
01:19 ET500174.52
01:21 ET350174.42
01:24 ET100174.27
01:26 ET700174.51
01:28 ET100174.86
01:30 ET200175.19
01:32 ET100175.16
01:33 ET200174.83
01:35 ET300174.68
01:37 ET200174.375
01:39 ET400174.34
01:42 ET124174.4
01:44 ET500174.63
01:48 ET500175.03
01:50 ET900175.32
01:51 ET100175.22
01:53 ET100175.075
01:55 ET600174.37
01:57 ET200174.38
02:00 ET300174.5125
02:02 ET200174.14
02:04 ET100174.1
02:06 ET200174.065
02:11 ET1135173.65
02:13 ET100173.6125
02:18 ET912173.53
02:20 ET1039173.645
02:22 ET200173.63
02:31 ET532173.74
02:36 ET100173.73
02:38 ET300173.47
02:42 ET600173.435
02:44 ET300173.235
02:45 ET300172.75
02:47 ET300172.965
02:51 ET700173.52
02:54 ET421173.165
02:56 ET346173.48
02:58 ET200173.54
03:00 ET500173.065
03:02 ET100172.8993
03:03 ET700172.575
03:05 ET200172.6175
03:12 ET800172.71
03:16 ET100172.5425
03:20 ET100172.42
03:23 ET300172.22
03:25 ET904172.04
03:27 ET100172.07
03:30 ET100171.975
03:32 ET700171.83
03:34 ET352171.805
03:36 ET2062172.49
03:39 ET913173.085
03:43 ET300172.56
03:48 ET412172.3
03:50 ET2400172.82
03:52 ET300172.43
03:54 ET3805173.13
03:56 ET400173
03:57 ET600173.03
03:59 ET20831172.85
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBGNE
Beigene Ltd
18.6B
-22.8x
---
United StatesBMRN
Biomarin Pharmaceutical Inc
14.7B
73.4x
---
United StatesALNY
Alnylam Pharmaceuticals Inc
18.9B
-55.1x
---
United StatesUTHR
United Therapeutics Corp
12.2B
13.0x
+8.22%
United StatesNBIX
Neurocrine Biosciences Inc
14.3B
39.1x
+62.04%
United StatesEXAS
Exact Sciences Corp
9.3B
-38.0x
---
As of 2024-05-19

Company Information

BeiGene, Ltd. is a global biotechnology company engaged in discovering and developing oncology treatments for cancer patients worldwide. The Company has discovered and developed three approved medicines, including BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase for the treatment of various blood cancers; TEVIMBRA (tislelizumab), an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and pamiparib, a selective small molecule inhibitor of poly ADP-ribose polymerase 1 (PARP1) and PARP2. The Company has obtained approvals to market BRUKINSA in the United States, the People's Republic of China (China or the PRC), the European Union, the United Kingdom, Canada, Australia, and additional international markets; tislelizumab in the European Union and China; and pamiparib in China. It also focuses on commercializing cancer medicines, such as XGEVA, BLINCYTO, KYPROLIS, and others in China under an exclusive license from Amgen Inc.

Contact Information

Headquarters
94 Solaris Avenue,, Camana BayGRAND CAYMAN, BEJ, Cayman Islands KY1-1108
Phone
345-949-4123
Fax
---

Executives

Co-Founder, Executive Chairman of the Board, Chief Executive Officer
John Oyler
President, Chief Operating Officer, General Manager - China
Xiaobin Wu
Co-Founder, Non-Executive Director
Xiaodong Wang
Chief Financial Officer
Julia Wang
Global Head of R&D
Lai Wang

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$18.6B
Revenue (TTM)
$2.8B
Shares Outstanding
104.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.64
EPS
$-7.57
Book Value
$36.95
P/E Ratio
-22.8x
Price/Sales (TTM)
6.7
Price/Cash Flow (TTM)
---
Operating Margin
-39.74%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.